Close

Ratings by Baird (Joel Beatty)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/10/2022 Arcturus Therapeutics ARCT Downgrade Underperform
(Neutral)
22.82
(17.67)
-22.57% Details
11/3/2022 Ultragenyx Pharma RARE Upgrade Outperform
(Neutral)
40.59
(39.83)
-1.87% Details
11/3/2022 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
7/29/2022 argenx SE ARGX Downgrade Neutral
(Outperform)
357.86
(393.26)
9.89% Details
5/11/2022 Arrowhead Pharma ARWR Upgrade Outperform
(Neutral)
32.72
(31.82)
-2.75% Details
5/11/2022 Arcturus Therapeutics ARCT Upgrade Neutral
(Underperform)
16.61
(17.67)
6.38% Details
5/10/2022 Syndax Pharmaceuticals SNDX Maintain Outperform
(N/A)
 
 
  Details
4/7/2022 Ambrx Biopharma AMAM New Coverage Outperform
(N/A)
4.07
(0.52)
-87.22% Details
4/4/2022 IGM Biosciences IGMS Maintain Outperform
(N/A)
 
 
  Details
3/3/2022 Vir Biotechnology VIR Upgrade Neutral
(Underperform)
24.13
(26.57)
10.11% Details
2/23/2022 Tracon Pharmaceuticals TCON New Coverage Outperform
(N/A)
2.41
(1.44)
-40.25% Details
12/21/2021 Vir Biotechnology VIR Downgrade Underperform
(Neutral)
53.92
(26.57)
-50.72% Details
11/17/2021 Vir Biotechnology VIR Maintain Neutral
(N/A)
 
 
  Details
11/2/2021 Geron Corporation GERN New Coverage Outperform
(N/A)
1.54
(2.29)
48.7% Details
9/9/2021 BeyondSpring Inc. BYSI New Coverage Outperform
(N/A)
23.46
(0.57)
-97.57% Details
8/10/2021 Arcturus Therapeutics ARCT Downgrade Underperform
(Neutral)
48.24
(17.67)
-63.37% Details
6/4/2021 Syndax Pharmaceuticals SNDX New Coverage Outperform
(N/A)
18.07
(25.44)
40.79% Details
6/4/2021 Nurix NRIX New Coverage Neutral
(N/A)
29.42
(12.38)
-57.92% Details
6/4/2021 Leap Therapeutics LPTX New Coverage Outperform
(N/A)
1.62
(0.52)
-67.9% Details
6/4/2021 IGM Biosciences IGMS New Coverage Outperform
(N/A)
80.87
(20.05)
-75.21% Details
6/4/2021 Atreca Inc. BCEL New Coverage Outperform
(N/A)
9.27
(1.00)
-89.21% Details
6/4/2021 argenx SE ARGX New Coverage Outperform
(N/A)
268.12
(393.26)
46.67% Details
6/4/2021 Arcturus Therapeutics ARCT New Coverage Neutral
(N/A)
31.13
(17.67)
-43.24% Details
6/4/2021 Vir Biotechnology VIR New Coverage Neutral
(N/A)
44.48
(26.57)
-40.27% Details
6/4/2021 Editas Medicine EDIT New Coverage Outperform
(N/A)
35.04
(9.83)
-71.95% Details
6/4/2021 Ideaya Biosciences IDYA New Coverage Outperform
(N/A)
20.18
(17.77)
-11.94% Details
6/4/2021 Blueprint Medicines BPMC New Coverage Outperform
(N/A)
87.13
(50.19)
-42.4% Details
6/4/2021 Arrowhead Pharma ARWR New Coverage Neutral
(N/A)
72.24
(31.82)
-55.95% Details
6/4/2021 BioMarin Pharmaceutical Inc. BMRN New Coverage Outperform
(N/A)
77.35
(103.53)
33.85% Details
6/4/2021 Ultragenyx Pharma RARE New Coverage Neutral
(N/A)
97.70
(39.83)
-59.23% Details